Form 8-K - Current report:
SEC Accession No. 0001140361-21-030391
Filing Date
2021-09-03
Accepted
2021-09-03 17:03:01
Documents
18
Period of Report
2021-09-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20000594x2_8k.htm   iXBRL 8-K 39705
2 EXHIBIT 1.1 ny20000594x2_ex1-1.htm EX-1.1 314862
3 EXHIBIT 5.1 ny20000594x2_ex5-1.htm EX-5.1 12463
8 ny20000594x2_ex5-1image01.jpg GRAPHIC 1140
9 ny20000594x2_ex5-1image02.jpg GRAPHIC 1148
10 ny20000594x2_ex5-1image03.jpg GRAPHIC 8123
  Complete submission text file 0001140361-21-030391.txt   630153

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adma-20210903.xsd EX-101.SCH 4377
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adma-20210903_def.xml EX-101.DEF 17551
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20210903_lab.xml EX-101.LAB 27040
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20210903_pre.xml EX-101.PRE 19730
11 EXTRACTED XBRL INSTANCE DOCUMENT ny20000594x2_8k_htm.xml XML 6009
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 211237282
SIC: 2836 Biological Products, (No Diagnostic Substances)